Health News Round Up: Bausch Health

Conflicts in Iraq and Afghanistan may have led to an increase in rates of post-traumatic stress disorder (PTSD), according to new research looking at the mental health of Britain's soldiers.

Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Bausch Health Cos Inc, formerly Valeant Pharmaceuticals, said on Monday it received tentative U.S. approval to market its plaque psoriasis lotion, Bryhali. The company plans to launch the lotion in November after receiving final approval from the Food and Drug Administration, pending expiration of exclusivity for a related product, Bausch said in a statement.